The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

Stocks turned in a lackluster performance Friday as Wall Street took a breather at the end of the first week of ...

But, for now at least, a steady if unspectacular job market and a stock market hitting new highs appears to be enough to keep ...

Here’s a puzzle that’s been bothering me: how can we be seeing substantial tariff revenues, and flattish inflation, and a ...

For most of the current decade, the global economy has been much softer than most businesses around the world would like.

Prepare for the 'year of tariffs' in 2025. Learn how escalating trade barriers and negotiations could impact markets and your ...

Investor sentiment has been infected by a complacency about the stock market. If this doesn't change soon, it could result in ...

President Donald Trump’s signature tax and spending legislation is providing short-term clarity for Wall Street but fueling concerns about the long-term health of the US economy, investors say.

Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...

Rochester banking leaders share insights on inflation, interest rates and local resilience amid 2025 economic and trade ...

Stocks were taken on a wild ride Wednesday as a White House official indicated to CNBC that Trump was moving closer to firing ...

Rachel Reeves wants to encourage a shift – but negative headlines about the risks could be making British consumers wary.